Difference between revisions of "Bevacizumab (Avastin)"
(Created page with "==General information== Class/mechanism: Monoclonal antibody that inhibits angiogenesis by binding VEGF and preventing the interaction of VEGF with its receptors (Flt-1 and KDR) ...") |
|||
| Line 7: | Line 7: | ||
==Patient drug information== | ==Patient drug information== | ||
| + | *[http://chemocare.com/bio/bevacizumab.asp Bevacizumab (Avastin) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/bevacizumab.asp Bevacizumab (Avastin) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/bevacizumab-patient-drug-information Bevacizumab (Avastin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/bevacizumab-patient-drug-information Bevacizumab (Avastin) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/bevacizumab-patient-drug-information Bevacizumab (Avastin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/bevacizumab-patient-drug-information Bevacizumab (Avastin) patient drug information (UpToDate)]</ref> | ||
Revision as of 18:43, 5 December 2011
General information
Class/mechanism: Monoclonal antibody that inhibits angiogenesis by binding VEGF and preventing the interaction of VEGF with its receptors (Flt-1 and KDR) on the surface of endothelial cells.[1][2]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Patient drug information
- Bevacizumab (Avastin) patient drug information (Chemocare)[3]
- Bevacizumab (Avastin) patient drug information (UpToDate)[4]
Regimens
Standard format will be:
<acronym (if any)> <generic drug1, generic drug2, generic drug3, etc.> (disease)